发布时间：2008.8

摘要

Countries covered: United States

This research service analyzes the changing dynamics in the U.S. human growth hormone market for the period 2004-2014. Included are a pipeline analysis, revenue forecast, patient forecast, market share analysis, product analysis and major trends such as drivers, challenges and restraints. The market is segmented by adult and pediatric. Overviews of the diseases and indications treated by human growth hormone are also provided along with current and future market landscape.

目录及图表

1 U.S. HUMAN GROWTH HORMONE MARKET

Overview

Title

Disclaimer and Certification

Table of Contents

Notes on Methodology

Market Introduction

Market Introduction

Human Growth Hormone: Definition

Human Growth Hormone Market: Market Overview

Product Analysis

Competitive Structure

Disease Overview and Drug Delivery Systems

Disease Overview and Drug Delivery Systems

FDA Approved Indications

Disease Overview

Therapy Guidelines

Pediatric Human Growth Hormone Market

Adult Human Growth Hormone Market

Drug Delivery Systems

New Indications and Challenges

Idiopathic Short Stature

Small for Gestational Age

Hot Topics

Hot Topics

The Debate on Bio-generics

Product Off-label and Investigational Uses

Debate on Off-label Use of Growth Hormone

Market Trends

Market Trends

Industry Challenges

Market Drivers

Market Restraints

Revenue Analysis

Revenue Analysis

Market Engineering Measurements

Patient Forecast

Therapy Cost and Treatment Patterns

Annual Treatment Costs Forecast

Revenue Forecasts

Market Share Analysis

Market Share Analysis

Company Market Share

Market Share Discussion

Clinical Developments and Pipeline

Clinical Developments and Pipeline

Clinical Developments

Ongoing Clinical Trials for Marketed Products

Company Profiles

Company Profiles

Genentech

Eli Lilly

Pfizer

Novo Nordisk

EMD Serono

Teva Pharmaceuticals

Sandoz

Conclusion

Conclusion

Future Competitive Landscape

About Frost & Sullivan

Frost & Sullivan